Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
39%
Viral Load
29%
Virus
24%
Prevalence
20%
Reverse Transcriptase
18%
Blood Plasma
18%
Drug Resistance
14%
Peptides
13%
CXCR4
13%
Natural Killer Cell
10%
Hepatitis C Virus
10%
Cladistics
10%
Integrase
9%
Amino Terminal Sequence
9%
Omicron Coronavirus Variant
9%
Breakthrough Infection
8%
Chemokine Receptor
8%
Cytotoxic T-Cell
8%
CD4 Lymphocyte Count
8%
Cross-Resistance
8%
Heavy Chain
8%
Molecular Epidemiology
7%
CCR5
7%
Hepatitis C
7%
Peripheral Blood Mononuclear Cell
7%
Bacteriophage
7%
T-Helper Cell
6%
Structural Gene
6%
Chemokine
6%
Neutralization
6%
Humanized Mouse
6%
CD4
6%
Disease Burden
6%
Dynamics
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Cell Surface
5%
Virus Infectivity
5%
Promoter Region
5%
Epitope
5%
Human Immunodeficiency Virus Infection
5%
Human Immunodeficiency Virus Type 1 Subtype C
5%
HIV Type 1
5%
Hepatitis B
5%
Hepatitis B Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
84%
Prevalence
32%
Drug Resistance
27%
Infection
24%
Diseases
21%
Hepatitis C Virus
20%
Hepatitis C
16%
Elimination
14%
Antivirus Agent
14%
Integrase
11%
Virus Hepatitis
11%
Human Immunodeficiency Virus 1
11%
Antiviral Drug
10%
Proteinase Inhibitor
10%
Lamivudine
10%
Hepatitis B Virus
10%
Hepatitis B
9%
Anti-Human Immunodeficiency Virus
8%
Human Immunodeficiency Virus Infection
7%
Efavirenz
6%
Chemokine Receptor
6%
HIV Drug Resistance
6%
Zidovudine
6%
Proteinase
6%
Cassia
5%
Ritonavir
5%
RNA Directed DNA Polymerase
5%
Chemokine
5%
Chronic Hepatitis C
5%
Nucleic Acid
5%
Nucleocapsid Protein
5%
Keyphrases
Europe
10%
People Who Inject Drugs
7%
EMCDDA
6%
AIDS/HIV
6%
Plasma Viral Load
5%
Protein Complex
5%
HIV Protease Inhibitors
5%
Transmission Dynamics
5%
Highly Active Antiretroviral Therapy (HAART)
5%
Functional Components
5%